Bodyport and Geisinger to Launch Innovative Heart Failure Monitoring Program

Noninvasive remote technology focuses on early detection and prevention

SAN FRANCISCO, Aug. 2, 2023 /PRNewswire/ -- Bodyport Inc., a virtual care company focused on heart failure, and Geisinger, an integrated health care delivery and coverage organization serving members in central and northeastern Pennsylvania, today announced they will collaborate to develop and implement a fluid-guided care pathway for heart failure. The pathway will augment Geisinger's existing remote heart failure (HF) management program by incorporating the FDA-cleared Bodyport Cardiac Scale and Fluid Alerts.

"We're excited to be working with Geisinger, which is known for its expertise in providing value-based care and delivering innovative and effective heart failure care that incorporates the most advanced therapies and solutions available," said John Lipman, chief executive officer of Bodyport. "Geisinger and Bodyport share in common a preventive approach to care that focuses on keeping patients healthy by helping them avoid worsening heart failure events, a key driver of healthcare costs."

As the buildup of fluid is a key indicator of worsening HF, the goal of the program is to operationalize a fluid-guided care pathway that provides an earlier warning of changes in status to improve care delivery and clinical outcomes for HF patients using the Bodyport Cardiac Scale.

"Geisinger's approach to caring for patients with heart failure is built on incorporating leading-edge treatments and solutions," said Vishal Mehra, MD, system chief of quality and value for Geisinger's Heart Institute. "Based on our common commitment to preventive care and the successes we've already realized together in detecting heart failure events earlier and more accurately, we look forward to assessing the efficacy of the Bodyport model in a more prospective manner. We're glad to be continuing our work with Bodyport in hopes of building even more value into the care we provide for our patients."

Similar in form to a conventional weight scale, the Bodyport Cardiac Scale is a physical platform with embedded sensors that non-invasively measure metrics of heart function and fluid status in the same step patients take to weigh themselves each day. The Bodyport Fluid Alert incorporates changes in weight, fluid levels, and pulse rate measured through the Cardiac Scale to remotely notify care teams of changes in a patient's health status.

This kind of noninvasive remote monitoring can help care teams proactively provide medical interventions to patients to avoid worsening heart failure events and the associated costs of preventable hospitalizations. The data gathered by the Cardiac Scale also informs self-care insights provided through Bodyport's user-friendly patient app.

Over the 12-month pilot phase of the program, approximately 200 of Geisinger's adult patients diagnosed with HF will be provided the Cardiac Scale for daily home use. The measurement data from the scale will be automatically uploaded to the Geisinger medical team, who will be notified of any alerts generated and will reach out to the patient to remotely assess status, provide coaching on HF risk factors, and determine whether to activate or escalate treatment. The program builds on the success of an earlier study conducted by Geisinger and Bodyport that evaluated the efficacy of the Fluid Alert to detect worsening heart failure in 100 Geisinger patients with HF. The earlier study showed the Bodyport Fluid Alert was able to detect HF events earlier, more accurately, and with fewer false alerts than weight-based monitoring alone, the current standard of care for HF patients.

About Bodyport

Bodyport is a biomarker-guided predictive care company on a mission to address complex chronic conditions by embedding a sophisticated biomarker platform into simple, easy-to-use devices. Dedicated to keeping patients with cardiorenal conditions healthier and out of the hospital, the company is initially focused on heart failure patients and the noninvasive assessment of heart function and fluid status in a single step at home. The Bodyport Heart Health solution captures hemodynamic signals through the FDA-cleared Bodyport Cardiac Scale to power optimized interventions tailored to the patient. Learn more at bodyport.com or connect with us on LinkedIn.

About Geisinger

Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and Twitter.

Media Contact:

Jeff Christensen
SignalWest Public Relations
(831) 566-0275
[email protected]

SOURCE Bodyport Inc.